Massachusetts Eye and Ear Enters Licensing Agreement with Biogen to Develop Treatment for Inherited Retinal Disorder

Mass General Brigham Innovation Fund Licensing Agreement with Biogen to Focus on Developing Treatment for Inherited Retinal Degeneration Due to Mutations in the PRPF31 Gene July, 2, 2020: (BOSTON) – Massachusetts Eye and Ear, a member…

Massachusetts Eye and Ear and Massachusetts General Hospital Advancing Novel Experimental Gene-based COVID-19 Vaccine, AAVCOVID

Massachusetts Eye and Ear and Massachusetts General Hospital (MGH) today announced progress towards the testing and development of an experimental vaccine called AAVCOVID, a novel gene-based vaccine candidate against SARS-CoV2, the virus that causes COVID-19. The…

How Does My Idea Fit Into a Commercial Landscape?

Medical research can be an electrifying experience as novel ideas are turned into life-altering solutions. On the other hand, research can also be incredibly frustrating, especially when your work has reached a desired result, yet, you’re not certain…

Bayer Pharma Reflections on Innovation: Creating, Collaborating, and Accelerating Discovery During and After a Pandemic

At the 2020 World Medical Innovation Forum, Joerg Moeller, MD, PhD reflected on how Bayer is weathering the organizational challenges posed by the COVID-19 pandemic. Moderated by Janet Wu of Bloomberg, this fireside chat covered possible…

Sorry, we couldn't find any posts. Please try a different search.

The 2020 Disruptive Dozen

TOP 12 DISRUPTIVE HEALTHCARE TECHNOLOGIES Mapping spread of infectious diseases and reducing health disparities top list Mass General Brigham announced its selections for the sixth annual “Disruptive Dozen,” the 12 emerging clinical and artificial intelligence technologies…

Recent Posts by Category

AI Insights: Cardiovascular Care

Cardiovascular diseases remain the leading cause of death worldwide and rising expense, making this area ripe for AI-enabled innovations. This AI Update includes discussions…

The 2020 Disruptive Dozen

TOP 12 DISRUPTIVE HEALTHCARE TECHNOLOGIES Mapping spread of infectious diseases and reducing health disparities top list Mass General Brigham announced its selections for the…

Innovation Fellows Gain Valuable Industry Connections

The Partners Innovation Fellows Program provides up-and-coming faculty/staff physicians and investigators from Partners   with an opportunity to work with an industry partner on an…

Drug Delivery Directly to the Tumor

Historically, scientists have thought of cancer cells as a clone army—since they are all genetically identical, they are universally bad actors. “What we’ve learned…

New Imaging Tools Could Reduce the Deadly Toll of Thrombus and Fibrosis

Diseases related to thrombus and fibrosis are a key contributor to strokes, heart attacks, organ failure and death and result in billions of dollars…

Realizing the Promise of AI in the Clinic

The gap between the development of AI and its use and integration in the clinic is closing, as technology, sophisticated algorithms, data sets, and…

Massachusetts Eye and Ear Enters Licensing Agreement with Biogen to Develop Treatment for Inherited Retinal Disorder

Mass General Brigham Innovation Fund Licensing Agreement with Biogen to Focus on Developing Treatment for Inherited Retinal Degeneration Due to Mutations in the PRPF31…

A Q&A with Roger Kitterman

How do these new funds enhance the Partners Innovation Fund? These funds extend the capabilities we built with PIF.  TIF will allow us to…

Bayer Pharma Reflections on Innovation: Creating, Collaborating, and Accelerating Discovery During and After a Pandemic

At the 2020 World Medical Innovation Forum, Joerg Moeller, MD, PhD reflected on how Bayer is weathering the organizational challenges posed by the COVID-19…

The 2020 Disruptive Dozen

June 1, 2020

TOP 12 DISRUPTIVE HEALTHCARE TECHNOLOGIES Mapping spread of infectious diseases and reducing health disparities top list Mass General Brigham announced its selections for the sixth annual “Disruptive Dozen,” the 12 emerging clinical and artificial intelligence technologies with the greatest potential to impact health care in the next year. The Disruptive…

Read More

Partners HealthCare Creates New Investment Funds to Accelerate Innovation in Medicine

October 21, 2019

$80M Investment to Speed Discovery from Lab to Patient, Fuel Life Sciences Economy Partners HealthCare has announced the creation of two new investment funds aimed at addressing the lack of translational funding in pre-clinical life sciences, Artificial Intelligence (AI) and digital technology development. The funds will support ventures that develop…

Read More

New “Staff Accelerator” Program Emphasizes Life-Long Learning and Commercialization Excellence

February 21, 2019

Developing people and keeping pace with the rapidly changing world of healthcare innovation is at the heart of a new “Staff Accelerator” (SA) pilot program just launched at Partners HealthCare Innovation. Combining mentoring programs, developmental opportunities and career and skills development workshops, the SA program is just one part of…

Read More

Pfizer Centers for Therapeutic Innovation: Fall 2018 Call-for-Proposals due November 2nd 2018

September 20, 2018

We are pleased to alert you to the call for proposals for Pfizer’s Centers for Therapeutic Innovation (CTI) program for collaborative development of novel biotherapeutics. CTI supports translational programs in oncology, autoimmunity & inflammation, metabolic and rare diseases. Deadline to submit to Innovation:  Friday, November 2nd 2018 How to apply:  Please use…

Read More

2019 Partners Innovation Discovery Grant Program: REQUEST FOR APPLICATIONS

July 30, 2018

We are delighted to announce the fourth round of the Innovation Discovery Grants Program (IDG). Partners HealthCare has renewed this grant program to stimulate new inventive concepts, identify areas of commercially significant scientific strength, and accelerate the creation of new products from the innovations of all Partners employees and faculty.…

Read More

Innovators Honored at 2nd Annual Dinner

June 21, 2018

The Innovator’s Dinner was held Wednesday evening, April 25th as the concluding event of the 2018 World Medical Innovation Forum. This invitation-only dinner honored the 660 MGH, BWH, McLean and Spaulding principal investigators who submitted an invention disclosure during the calendar year 2017. Each investigator was recognized with a framed…

Read More